FI943872A - 2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina - Google Patents

2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina Download PDF

Info

Publication number
FI943872A
FI943872A FI943872A FI943872A FI943872A FI 943872 A FI943872 A FI 943872A FI 943872 A FI943872 A FI 943872A FI 943872 A FI943872 A FI 943872A FI 943872 A FI943872 A FI 943872A
Authority
FI
Finland
Prior art keywords
cacicin
methano
derivative
receptor antagonist
antagonist
Prior art date
Application number
FI943872A
Other languages
English (en)
Swedish (sv)
Other versions
FI943872A0 (fi
FI105917B (fi
Inventor
Maurice Ward Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI943872A0 publication Critical patent/FI943872A0/fi
Publication of FI943872A publication Critical patent/FI943872A/fi
Application granted granted Critical
Publication of FI105917B publication Critical patent/FI105917B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI943872A 1992-02-24 1994-08-23 Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi FI105917B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92400474 1992-02-24
EP92400474 1992-02-24
PCT/US1993/000880 WO1993017019A1 (en) 1992-02-24 1993-02-03 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist
US9300880 1993-02-03

Publications (3)

Publication Number Publication Date
FI943872A0 FI943872A0 (fi) 1994-08-23
FI943872A true FI943872A (fi) 1994-08-23
FI105917B FI105917B (fi) 2000-10-31

Family

ID=8211614

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943872A FI105917B (fi) 1992-02-24 1994-08-23 Menetelmä terapeuttisesti aktiivisen 5-kloori-2,3-dihydro-2,2-dimetyylibentsofuraani-7-karboksyylihappo-oktahydro-3-hydroksi-2,6-metano-2H-kinolitsin-8-yyliesterin valmistamiseksi

Country Status (14)

Country Link
EP (1) EP0628043A1 (fi)
JP (1) JPH07504192A (fi)
KR (1) KR100287933B1 (fi)
AU (1) AU675060B2 (fi)
CA (1) CA2130563C (fi)
FI (1) FI105917B (fi)
HU (1) HU216831B (fi)
IL (1) IL104821A (fi)
MX (1) MX9300948A (fi)
NO (1) NO943101D0 (fi)
NZ (1) NZ249346A (fi)
TW (1) TW226374B (fi)
WO (1) WO1993017019A1 (fi)
ZA (1) ZA931146B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048597A1 (en) 1999-02-18 2000-08-24 Novartis Ag Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
EP1861096B1 (en) 2005-03-07 2018-12-26 The University of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en) 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080727T3 (es) * 1988-02-23 1996-02-16 Merrell Pharma Inc Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos.
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
KR100287933B1 (ko) 2001-05-02
IL104821A (en) 1997-01-10
FI943872A0 (fi) 1994-08-23
NZ249346A (en) 1995-10-26
EP0628043A1 (en) 1994-12-14
NO943101L (no) 1994-08-23
WO1993017019A1 (en) 1993-09-02
MX9300948A (es) 1993-08-01
KR950700297A (ko) 1995-01-16
AU675060B2 (en) 1997-01-23
AU3603493A (en) 1993-09-13
CA2130563C (en) 1997-11-11
IL104821A0 (en) 1993-06-10
NO943101D0 (no) 1994-08-23
CA2130563A1 (en) 1993-09-02
HU9402436D0 (en) 1994-10-28
FI105917B (fi) 2000-10-31
JPH07504192A (ja) 1995-05-11
HUT68249A (en) 1995-06-28
HU216831B (hu) 1999-09-28
TW226374B (fi) 1994-07-11
ZA931146B (en) 1993-09-14

Similar Documents

Publication Publication Date Title
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
DK0804419T3 (da) Quinolinderivater som tachykinin NK 3-receptor-antagonister
DE69207351T2 (de) Fibrinogen-Rezeptor-Antagoniste
DE69431604D1 (de) Benzofuranderivate als tachykininantagonisten
AU4718093A (en) Substituted amines as tachykinin receptor antagonists
KR900700569A (ko) 2,3-디플루오로벤젠 유도체
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
NO930306L (no) Nye 1,4-dihydropyridinderivater
NO923382L (no) Nye, terapeutisk virksomme benzopyranderivater
AU2759892A (en) N-aryl-n1-azabicyclo-ureas as 5-ht3 antagonists
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO179550C (no) Tachykinin reseptorantagonister
FI941372A0 (fi) Järjestely puomia varten
FI943872A (fi) 2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina
NO930262D0 (no) Bombesin-antagonister
DE69216466D1 (de) Substituierte 2,3-Dihydroperimidine, als Beständigkeitsmittel
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
DE69714019T2 (de) 1,4-dihydropyridin-verbindungen als bradykinin-antagonisten
DE69208043T2 (de) Zusammentragmaschine
GB2269747B (en) Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists
NO943547D0 (no) N-t-butyl-androst-3,5-dien-17 , polymorf A
ITUD920147A0 (it) Perforatrice orizzontale
ITUD920146A1 (it) Perforatrice orizzontale
KR930002370U (ko) 못치는 기계
FI924789A (fi) Gamma-interferoners loesliga, stympade receptor

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MA Patent expired